Discontinuation of blood pressure-lowering, glucose-lowering, and lipid-lowering medications after bariatric surgery in patients with morbid obesity: a nationwide cohort study in South Korea.
Soo Min JeonYeongkeun KwonDohyang KimJinseub HwangYoonseok HeoSungsoo ParkJin-Won KwonPublished in: Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery (2024)
BS was associated with a decrease in the use of medications for hypertension, diabetes mellitus (DM), and dyslipidemia.